A Study to Evaluate Fecal Microbiota Transplantation Engraftment in IBS
Completed · Phase 1 · Has a placebo group
Conditions studied: Irritable Bowel Syndrome
In brief
This is a randomized pilot study to characterize engraftment of a donor's microflora onto patients with Irritable Bowel Syndrome with diarrhea following fecal microbiota transplantation.
Key facts
- Study ID
- NCT02847481
- Run by
- Beth Israel Deaconess Medical Center
- People needed
- 80
- Starts
- 2016-05-01
- Expected to finish
- 2018-08-05
- Last updated by the study team
- 2019-12-23
Who can join
Age: 18 and older. Sex: any. Healthy volunteers: not accepted.
You may qualify if…
- IBS with diarrhea
Where it is running
- Beth Israel Deaconess Medical Center — Boston, Massachusetts, United States
Full record on ClinicalTrials.gov
Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.